3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
41
Lung Neoplasms
11
Neoplasm Metastasis
5
Carcinoma
4
Neoplasms
3
Brain Neoplasms
3
Stomach Neoplasms
2
NSCLC
2
Multiple Myeloma
2
Lymphoma
2
Hematologic Neoplasms
2
Colorectal Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stage II-IIIB Non-small Cell Lung Carcinoma
1
Stage IB-IIIA Non-small Cell Lung Carcinoma
1
Squamous Cell Carcinoma of Head and Neck
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Non-small Cell Carcinoma
1
Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor (Disorder)
1
Melanoma
1
Head and Neck Neoplasms
1
Glioma
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Interventions
osimertinib
1
Pemetrexed
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Non-small Cell Carcinoma
×
osimertinib
×
Clear all
NCT04695925
2025-10-15
TOP
Sun Yat-sen University
Phase 3
Active not recruiting
294 enrolled